Full Press Release Details
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer.
VKTX
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
Key Takeaway: Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
Price reaction · baseline $32.3 (2026-01-06 close) · hit after-hours · 5 other VKTX headline(s) in the window, move may be shared
day 0 close
+0.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss